|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/28 | |
| A61P 3/10 | |||
| C07K 14/62 |
| (11) | Patento numeris | 2869830 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13734772.0 |
| Europos patento paraiškos padavimo data | 2013-07-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-10-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/064392 |
| Data | 2013-07-08 |
| (87) | Numeris | WO 2014/009316 |
| Data | 2014-01-16 |
| (30) | Numeris | Data | Šalis |
| 12175525 | 2012-07-09 | EP | |
| 201261671912 P | 2012-07-16 | US | |
| 13157728 | 2013-03-05 | EP | |
| 201361778556 P | 2013-03-13 | US |
| (72) |
PRIDAL, Lone, DK
NAVER, Helle, DK
MADSEN, Peter, DK
KJELDSEN, Thomas B rglum, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | NOVEL USE OF INSULIN DERIVATIVES |
| NOVEL USE OF INSULIN DERIVATIVES |